Sale Reduces Cash Burn, Includes Seven-Year Earn-Out Provision;Third Quarter Revenue Expected to be Approximately $2.5 Million; Active Customer Sites Increase 18% YoY SOUTH ORANGE, NJ, Oct. 11, 2022 ...
LexaGene Holdings, Inc., a molecular diagnostics company that develops fully automated, rapid pathogen detection systems, has successfully utilized the MiQLab™ System to detect the presence of a slow ...
When you think of electric fields, you likely think of electricity — the stuff that makes modern life possible by powering everything from household appliances to cellphones. Researchers have been ...
The Myhrvold lab develops CRISPR-based technologies for studying RNA. Our primary interest is RNAs involved in host-pathogen interactions. We use a variety of RNA viruses and other pathogens as model ...
FORT DETRICK, Md. – Researchers at the U.S. Army Medical Research Institute of Infectious Diseases are testing a promising new biological threat detection method in high-fidelity training scenarios, ...
Researchers at Karolinska Institute have developed a novel method using DNA nanoballs to detect pathogens, aiming to simplify nucleic acid testing and revolutionize pathogen detection. The study's ...
It looks like an inhaler for treating asthma, but it could help biodefense experts sleep easier at night. BioSim, from Kansas City, Mo.-based Sceptor Industries http ...
A groundbreaking seven-year study reveals how metagenomic sequencing offers a more accurate, comprehensive approach to diagnosing difficult CNS infections—spotting pathogens that traditional tests ...
The company has entered into an asset purchase agreement pursuant to which it will sell substantially all of its assets used in its PDS business to BWSI, a privately held firm that invests in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback